Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

MCR-1 thought to be 'circulating' in the US
pig
MCR-1 was first discovered in multiple samples from pigs, pork and humans in China late last year.(stock photo)
Second pig sample found to contain colistin-resistant bacteria
 
US health officials have found bacteria that is resistant to the 'last resort' antibiotic, colistin, in a second pig sample. A similar discovery was made last month in a human patient.

Experts say there is growing evidence that the MCR-1 gene - which allows bacteria to become resistant to colistin - is circulating in the US. It is feared the gene could spread to bacteria that can only be treated with colistin, creating a superbug that is immune to all available antibiotics.

The latest discovery was made during testing at a slaughterhouse in Illinois, according to the Washington Post. E.coli bacteria carrying the gene was identified in a pig intestine, a spokeswoman for the US Department of Agriculture is reported to have said.

This is the second pig sample in the US found to contain resistant bacteria. A different strain of E.coli carrying MCR-1 was discovered in the intestines of a pig from another state last month.

For the first time, MCR-1 was also detected in a human patient in the US. E.coli bacteria carrying the gene was identified in a urine sample from the 49-year-old Pennsylvania resident.

Patrick McGann from the US Department of Defense, is quoted by the Washington Post as saying: "Mounting evidence suggests the MCR-1 gene is circulating within the United States. Our sample was in a woman with no recent travel history, the pig samples are from slaughterhouses in the USA, and [the] strains are all different."

Scientists across the globe have been looking for the gene since it was first discovered in multiple samples from pigs, pork and humans in China late last year.

Colistin is one of the last resort drugs, used to treat bacteria that is resistant to other antibiotics. The concern is that MCR-1 exists on a plasmid - a small piece of DNA - that can move from one bacterium to another, spreading antibiotic resistance. The gene has since been found in Europe and Canada, as well as the US.

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
CVS Group hit by cyber attack

CVS Group, which owns more than 450 veterinary practices in the UK, has been hit by a cyber attack.

In a statement, the group said the incident involved unauthorised external access to a limited number of its IT systems. As soon as the attack was discovered, the group took its IT systems temporarily offline, causing 'considerable operational disruption'.

It has warned that the security steps taken and ongoing plans to move its operational systems and IT infrastructure to the Cloud are likely to have an ongoing impact over a number of weeks.

Due to the risk that personal information was accessed, CVS has informed the Information Commissioner's Office. The company is working with third party consultants to investigate the incident.